期刊文献+

川芎嗪联合低分子肝素治疗原发性肾病综合征的疗效观察

Rhizome of Chuanxiongqin Unites Curative Effect which Low Molecular Heparin Treatment Primary Nephrosis Synthesis Drafts
原文传递
导出
摘要 目的:探讨在常规治疗基础上川芎嗪(商品名:川青)联合低分子肝素(商品名:速碧林)对原发性肾病综合征(PNS)的治疗效果。方法:将45例原发性肾病综合征患者随机分为2组,分别为常规治疗组(对照组)22例及川芎嗪联合低分子肝素治疗组(治疗组)23例,对照组给予激素、潘生丁、ACEI等药物治疗,治疗组在此基础上加用川芎嗪及低分子肝素。结果:治疗组与对照组治疗14天相比,其甘油三脂(TG)、胆固醇(TC)、血浆粘度、24小时尿蛋白定量、血肌酐均明显下降(P<0.05),血浆蛋白明显上升(P<0.05)。结论:在常规治疗基础上川芎嗪联合低分子肝素治疗PNS是一种有效的方法。 Objective: To discuss in conventional treatment foundation rhizome of chuanxiongqin (business commodity name: Siehuan blue) unites the low molecular heparin (business commodity name: The fast blue forest) drafts (PNS) to the primary nephrosis synthesis the treatment result. Methods: 45 cases of primary nephrosis synthesis the patient were divided into staehastically two groups, respectively (control group) 22 examples and the rhizome of chuanxiongqin unites the low molecular heparin treatment group be the conventional treatment group (treatment group) 23 examples, the control group gave the hormone, medicine treatments and so on Pan Shengding, ACEI, the treatment group added in this foundation with the rhizome of chuanxiongqin and the low molecular heparin. Result: Treatment group and the control group were treated 14 day to compare, its glycerin (TG), cholesterol (TC), blood plasma viscosity, 24 hour urine protein quota, blood myo--bitter wine obvious drod (P〈0.05), protein substitute for plasma obvious rise (P〈0.05). Conclusion: The rhizome of chuanxiongqin unites the low molecular heparin in the conventional treatment foundation to treat PNS might be one effective method.
出处 《中国伤残医学》 2008年第2期19-21,共3页 Chinese Journal of Trauma and Disability Medicine
关键词 川芎嗪 低分子肝素 原发性肾病综合征 Chuanxiongqin Low member heparin Primary nephrosis synthesis drains
  • 相关文献

参考文献4

二级参考文献22

共引文献96

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部